What risk factors are associated with posterior reversible encephalopathy syndrome (PRES)?

Intern Med J. 2005 Feb;35(2):83-90.
Stott VL, et al.   Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.
Review of clinical presentation, diagnosis and management of PRES syndrome (also known as reversible posterior leukoencephalopathy syndrome (RPLS).

Causes and Risk Factors section of the Reversible posterior leukoencephalopathy syndrome (RPLS) article in DynaMed identifies medical conditions and medications associated with development of PRES, including immunosuppressants, methotrexate, bevacizumab, cisplatin, preeclampsia-eclampsia, HUS, sepsis, hyponatremia

Revision of May 14, 2011 post


About Amy

Clinical Informationist at EUH Branch Library
This entry was posted in Background question, EUH and tagged . Bookmark the permalink.